STOCK TITAN

Jennifer Michaelson (CGEM) files Form 144: option exercise and 10b5-1 sales

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Jennifer Michaelson reported Form 144 proposed sales of Common shares. The filing lists an exercise of stock options for 4,000 shares dated 03/05/2026 and 4,000 Restricted Stock Units dated 12/11/2024.

The excerpt also itemizes multiple 10b5-1 sale transactions by Ms. Michaelson during late 2025 and early 2026, including 8,000 shares on 02/20/2026, 4,000 shares on 01/22/2026, and smaller lots on various dates with dollar amounts shown.

Positive

  • None.

Negative

  • None.

Insights

Form 144 lists option exercise and scheduled insider sales under a 10b5-1 plan.

The filing records an exercise of stock options for 4,000 shares on 03/05/2026 and 4,000 Restricted Stock Units dated 12/11/2024, alongside multiple 10b5-1 sales in late 2025 and early 2026. The excerpt shows specific sell lots (for example, 8,000 shares on 02/20/2026).

Cash-flow treatment is identified per-line by the reported proceeds for each sale; broader impact depends on total holdings and company context not provided here. Subsequent filings may disclose additional quantities or finalize transactions.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does CGEM Form 144 say about Jennifer Michaelson's transactions?

It reports proposed sales of Common shares and recent 10b5-1 sales. The filing lists an option exercise of 4,000 shares on 03/05/2026 and multiple 10b5-1 sale lots in late 2025 and early 2026 with per‑trade proceeds shown.

How many shares were exercised or issued to Jennifer Michaelson per the filing?

The excerpt shows 4,000 shares exercised and 4,000 Restricted Stock Units. The exercise is dated 03/05/2026 and the RSUs carry the date 12/11/2024 as listed in the filing.

Which 10b5-1 sale volumes are shown in the CGEM excerpt?

The filing lists multiple 10b5-1 sale lots, including 8,000 shares on 02/20/2026, 4,000 shares on 01/22/2026, and several smaller transactions between December 2025 and February 2026, each with the reported proceeds.

Do the Form 144 entries show dollar proceeds for the sales?

Yes; each 10b5-1 sale line in the excerpt includes reported proceeds for that lot. Examples include $114,400.00 for 8,000 shares on 02/20/2026 and $49,200.00 for 4,000 shares on 01/22/2026.
Cullinan Oncology Inc

NASDAQ:CGEM

View CGEM Stock Overview

CGEM Rankings

CGEM Latest News

CGEM Latest SEC Filings

CGEM Stock Data

880.83M
57.86M
Biotechnology
Biological Products, (no Diagnostic Substances)
Link
United States
CAMBRIDGE